Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 764.6 INR -2.6% Market Closed
Market Cap: 345.4B INR

Intrinsic Value

The intrinsic value of one AJANTPHARM stock under the Base Case scenario is 2 161.93 INR. Compared to the current market price of 2 764.6 INR, Ajanta Pharma Ltd is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AJANTPHARM Intrinsic Value
2 161.93 INR
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ajanta Pharma Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about AJANTPHARM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AJANTPHARM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ajanta Pharma Ltd.

Explain Valuation
Compare AJANTPHARM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AJANTPHARM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ajanta Pharma Ltd

Current Assets 33.9B
Cash & Short-Term Investments 9.5B
Receivables 14.5B
Other Current Assets 10B
Non-Current Assets 22.8B
Long-Term Investments 329.9m
PP&E 19.8B
Intangibles 412m
Other Non-Current Assets 2.3B
Current Liabilities 11.6B
Accounts Payable 4.3B
Other Current Liabilities 7.3B
Non-Current Liabilities 2B
Long-Term Debt 361.4m
Other Non-Current Liabilities 1.6B
Efficiency

Free Cash Flow Analysis
Ajanta Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ajanta Pharma Ltd

Revenue
49.7B INR
Cost of Revenue
-11.3B INR
Gross Profit
38.4B INR
Operating Expenses
-26.4B INR
Operating Income
12B INR
Other Expenses
-2.3B INR
Net Income
9.7B INR
Fundamental Scores

AJANTPHARM Profitability Score
Profitability Due Diligence

Ajanta Pharma Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Positive 3Y Average ROE
Positive ROIC
Exceptional Gross Margin
64/100
Profitability
Score

Ajanta Pharma Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

AJANTPHARM Solvency Score
Solvency Due Diligence

Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
97/100
Solvency
Score

Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AJANTPHARM Price Targets Summary
Ajanta Pharma Ltd

Wall Street analysts forecast AJANTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AJANTPHARM is 3 088.17 INR with a low forecast of 2 498.74 INR and a high forecast of 3 457.65 INR.

Lowest
Price Target
2 498.74 INR
10% Downside
Average
Price Target
3 088.17 INR
12% Upside
Highest
Price Target
3 457.65 INR
25% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AJANTPHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one AJANTPHARM stock?

The intrinsic value of one AJANTPHARM stock under the Base Case scenario is 2 161.93 INR.

Is AJANTPHARM stock undervalued or overvalued?

Compared to the current market price of 2 764.6 INR, Ajanta Pharma Ltd is Overvalued by 22%.

Back to Top